ConductScience.org, home

Paper32043984

Corticosteroids in acute respiratory distress syndrome: a step forward, but more evidence is needed.

Reddy K and 2 others. Lancet Respir Med, 2020. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Corticosteroids in acute respiratory distress syndrome: a step forward, but more evidence is needed. Papers, record 32043984. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32043984

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Corticosteroids in acute respiratory distress syndrome: a step forward, but more evidence is needed.
PubMed
Journal
Lancet Respir Med
PubMed
Year
2020
PubMed
Publication types
Journal Article, Comment
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.31
iCite
Revised in PubMed
2020-12-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Reddy KKiran
2O'Kane CCecilia
3McAuley DDaniel

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Respiratory Distress SyndromeMajor topic
Adrenal Cortex Hormones
Dexamethasone
Dyspnea
Humans

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment on32043986Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial.https://conductscience.org/library/papers/32043986

Source PubMed

Download CSV of comments and corrections

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
34786082Neutrophil-to-lymphocyte ratio is a powerful predictor of adult patients with acute respiratory distress syndrome who might benefit from corticosteroid therapy.Am J Transl Res2021https://conductscience.org/library/papers/34786082PubMed
34726496Identification and Development of Therapeutics for COVID-19.mSystems2021https://conductscience.org/library/papers/34726496PubMed
34303107Nonsteroidal anti-inflammatory drugs and glucocorticoids in COVID-19.Adv Biol Regul2021https://conductscience.org/library/papers/34303107PubMed
34118347Recent advances in potential drug therapies combating COVID-19 and related coronaviruses-A perspective.Food Chem Toxicol2021https://conductscience.org/library/papers/34118347PubMed
33134384An Updated Understanding of the Current Emerging Respiratory Infection: COVID-19.Biomed Res Int2020https://conductscience.org/library/papers/33134384PubMed
32264897Acute respiratory distress syndrome subphenotypes and therapy responsive traits among preclinical models: protocol for a systematic review and meta-analysis.Respir Res2020https://conductscience.org/library/papers/32264897PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32043984

GET https://conductscience.org/api/papers/v1/32043984/authors